Precigen Inc. Aktie
?
Deine Einschätzung
Precigen Inc. Aktie
Was spricht für und gegen Precigen Inc. in den nächsten Jahren?
Pro
Kontra
Rendite von Precigen Inc. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Precigen Inc. | -0,93 % | -6,90 % | 3,35 % | 185,90 % | 16,38 % | 251,22 % | -8,51 % |
| Mighty River Power Ltd | 1,85 % | -0,61 % | -1,22 % | 6,58 % | 3,85 % | -10,00 % | -14,29 % |
| A2A SpA | -0,13 % | 1,34 % | 4,22 % | 8,35 % | 2,22 % | 41,57 % | 36,95 % |
| CEMIG ADR | -1,08 % | -2,11 % | 5,08 % | 20,78 % | 8,77 % | -16,96 % | 25,29 % |
Kommentare
News
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
On July 1, 2026, Precigen (NASDAQ:PGEN) Chief Financial Officer Harry Thomasian Jr. reported the sale of 200,000 shares of common stock in multiple open-market transactions between June 29 and July
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?
Harry Thomasian Jr. Chief Financial Officer of Precigen (NASDAQ:PGEN), reported the sale of 41,884 shares of common stock on May 28, 2026, as disclosed in the SEC Form 4 filing.
Transaction value
Precigen Q1 Earnings Call Highlights
Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025




